Amicus Therapeutics, Inc. Stock
Stocks
FOLD
US03152W1099
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.49 USD | +0.21% |
|
-.--% | +1.76% |
| 05-05 | BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says | MT |
| 04-29 | Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Global BMI Index | CI |
| Market Cap | 4.55B 3.97B 3.67B 3.44B 6.45B 429B 6.49B 43.59B 16.89B 211B 17.08B 16.71B 734B | P/E 2024 |
-51.1x | P/E 2025 | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 4.7B 4.1B 3.79B 3.55B 6.66B 443B 6.7B 45.01B 17.44B 218B 17.64B 17.26B 758B | EV / Sales 2024 |
5.69x | EV / Sales 2025 | 7.18x |
| Free-Float |
99.31% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Amicus Therapeutics, Inc.
| 1 day | +0.21% | ||
| 3 months | +0.42% | ||
| 6 months | +2.19% | ||
| Current year | +1.76% |
| Current year | 14.2 |  | 14.5 |
| 1 year | 5.51 | | 14.5 |
| 3 years | 5.51 | | 14.57 |
| 5 years | 5.51 | | 14.57 |
| 10 years | 4.41 | | 25.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Davis
PSD | President | 55 | 27/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-27 | Issuer sale | General Counsel | 1,264,993 | 0.4029% | ||
| 04-27 | Issuer sale | Director | 398,261 | 0.1268% | ||
| 04-27 | Issuer sale | Director | 395,940 | 0.1261% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | -.--% | +156.91% | +13.83% | 4.55B | |
| +0.86% | +2.10% | -9.91% | -4.10% | 43.13B | |
| +3.31% | +5.93% | +310.97% | +532.23% | 34.65B | |
| +2.84% | +2.14% | +9.34% | +45.55% | 30.03B | |
| -1.70% | -7.54% | +8.43% | -21.54% | 28B | |
| -1.90% | -1.56% | +10.24% | +22.81% | 24.45B | |
| -0.14% | +5.86% | - | - | 14.34B | |
| +0.68% | -1.53% | +48.76% | +108.76% | 13.14B | |
| +0.54% | -0.69% | +5.75% | +7.96% | 12.53B | |
| -0.26% | +1.15% | +98.13% | +79.60% | 12.25B | |
| Average | +0.46% | +0.68% | +70.96% | +87.23% | 21.71B | |
| Weighted average by Cap. | +0.72% | +1.25% | +67.79% | +109.28% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 528M 461M 427M 399M 749M 49.85B 754M 5.06B 1.96B 24.54B 1.98B 1.94B 85.2B | 634M 553M 512M 479M 899M 59.84B 905M 6.08B 2.35B 29.46B 2.38B 2.33B 102B |
| Net income | -56.11M -48.92M -45.31M -42.41M -79.54M -5.29B -80.02M -537M -208M -2.61B -211M -206M -9.05B | -27.11M -23.64M -21.89M -20.49M -38.43M -2.56B -38.67M -260M -101M -1.26B -102M -99.58M -4.37B |
| Net Debt | 194M 169M 156M 146M 275M 18.28B 276M 1.86B 719M 9B 727M 711M 31.24B | 149M 130M 120M 113M 211M 14.04B 212M 1.43B 553M 6.91B 559M 547M 24B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- FOLD Stock
Select your edition
All financial news and data tailored to specific country editions
